Affordable Access

Celiac disease: Serologic prevalence in patients with irritable bowel syndrome

Journal of Research in Medical Sciences
Medknow Publications
Publication Date
  • Original Article
  • Medicine


Background: The prevalence of irritable bowel syndrome (IBS) in the community is 10%–20% and have symptom based diagnostic criteria. Many symptoms of celiac disease (CD) with 1% prevalence in some communities can mimic IBS. Sensitive and specific serologic tests of CD can detect asymptomatic cases. The purpose of this study was to compare the level of anti-tissue-transglutaminase (tTG) IgA in IBS patients and controls group. Materials and Methods: This case-control study was performed at a University hospital in which 107 patients with IBS who met the Rome II criteria for their diagnosis were compared with 126 healthy age and sex-matched controls. Both groups were investigated for CD by analysis of their serum tTG IgA antibody with human recombinant antigen. Titers were positive containing over 10u/ml and borderline if they were between 4 and 10 u/ml. Result: 86 percent of IBS patients were female. The mean antibody level was 0.837 u/ml in IBS group and 0.933 u/ml in control group without any significant difference. Discussion and Conclusion: Results of this study may intensify disagreement on the situation of CD in IBS patients.

There are no comments yet on this publication. Be the first to share your thoughts.


Seen <100 times

More articles like this

Celiac disease: Serologic prevalence in patients w...

on Journal of research in medical... September 2012

The prevalence of celiac disease in patients fulfi...

on European Journal of Internal M... Jan 01, 2010
More articles like this..